FDA Letter API

Martin Farm - Konrad Martin

Letter data

Company
Martin Farm - Konrad Martin
Recipient
Konrad Martin | Part Owner | Martin Farm - Konrad Martin | 25511 County Road 46 | Nappanee | , | IN | 46550-9323 | United States | konradariel17@gmail.com
Issue date
2026-08-13
Posted date
Not available
FDA office
Division of Human and Animal Food Operations East VI
Subject
Not available
Product
Animal & Veterinary
CMS ID
664784
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

FDA closeout letter

Full source text

CLOSEOUT LETTER Martin Farm - Konrad Martin MARCS-CMS 664784 — August 13, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA EMAIL NO HARD COPY TO FOLLOW Product: Animal & Veterinary Recipient: Recipient Name Konrad Martin Recipient Title Part Owner Martin Farm - Konrad Martin 25511 County Road 46 Nappanee , IN 46550-9323 United States konradariel17@gmail.com Issuing Office: Division of Human and Animal Food Operations East VI United States Secondary Issuing Offices United States Dear Konrad Martin, The United States Food and Drug Administration has completed evaluation of your facility’s corrective actions in response to our Warning Letter CMS 664784, dated November 14, 2023. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities may further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your facility from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your facility to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ for CDR Kelli L. Wilkinson Branch Director, Office of Surveillance and Compliance Center for Veterinary Medicine U.S. Food and Drug Administration Tel: 313-393-8120 Content current as of: 08/21/2026 Regulated Product(s) Animal & Veterinary